Literature DB >> 24212879

Adipsia increases risk of death in patients with central diabetes insipidus.

Hiroshi Arima1, Toshihiko Wakabayashi, Tetsuya Nagatani, Masazumi Fujii, Akihiro Hirakawa, Takashi Murase, Yuko Yambe, Tsutomu Yamada, Fumiko Yamakawa, Ikuo Yamamori, Masako Yamauchi, Yutaka Oiso.   

Abstract

Central diabetes insipidus (CDI) is caused by deficiency of arginine vasopressin, an antidiuretic hormone. Patients with CDI manifest polyuria which is usually compensated for by increases in water intake. However, some patients are not able to sense thirst due to the destruction of osmoreceptors in the hypothalamus. These adipsic CDI patients are easily dehydrated and the consequent dehydration could be life-threatening. The objective of this study was to investigate the prognosis of adipsic CDI patients. We have reviewed 149 patients with CDI in three hospitals using databases of the electronic medical recording systems, and examined whether adipsia could affect the morbidity and mortality in CDI patients with multivariable analyses. Twenty-three patients with CDI were adipsic while the remaining 126 patients were non-adipsic. The multivariate analyses showed that the incidence of serious infections which required hospitalization was significantly higher in the adipsic CDI patients compared to that in non-adipsic CDI patients (p <0.001). A total of 6 patients with CDI died during the follow-up (median duration; 60 months, range 1 to 132 months). Four of them were adipsic, three of whom died of infection. The statistical analyses revealed that the risk of death in adipsic CDI patients was significantly higher than in non-adipsic patients (p =0.007). It is thus suggested that adipsic CDI patients were susceptible to serious infections which could be the causes of death.

Entities:  

Mesh:

Year:  2013        PMID: 24212879     DOI: 10.1507/endocrj.ej13-0368

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  9 in total

1.  ADIPSIC DIABETES INSIPIDUS AFTER SECOND RESECTION OF A HYPOTHAMIC ASTROCYTOMA.

Authors:  Yasir Elamin; AlAnoud AlAnazi; Zahra A Al Saeed; Fatimah M Alabdrabalnabi
Journal:  AACE Clin Case Rep       Date:  2020-08-06

Review 2.  Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.

Authors:  Xinyi Chin; Shao Wei Teo; Soo Ting Lim; Yong Hong Ng; How Chuan Han; Fabian Yap
Journal:  Eur J Clin Pharmacol       Date:  2022-02-23       Impact factor: 2.953

3.  Heterogenous patterns of recovery of thirst in adult patients with adipsic diabetes insipidus.

Authors:  M Cuesta; S Gupta; R Salehmohamed; R Dineen; M J Hannon; W Tormey; C J Thompson
Journal:  QJM       Date:  2015-09-25

4.  Managing adipsic diabetes insipidus following anterior communicating artery aneurysm in a subtropical climate.

Authors:  Brendan Nolan; Warrick J Inder
Journal:  Clin Case Rep       Date:  2016-06-01

Review 5.  Central diabetes insipidus.

Authors:  Hiroshi Arima; Yoshinori Azuma; Yoshiaki Morishita; Daisuke Hagiwara
Journal:  Nagoya J Med Sci       Date:  2016-12       Impact factor: 1.131

Review 6.  Induction of Functional Hypothalamus and Pituitary Tissues From Pluripotent Stem Cells for Regenerative Medicine.

Authors:  Mayuko Kano; Hidetaka Suga; Hiroshi Arima
Journal:  J Endocr Soc       Date:  2020-12-02

7.  Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center.

Authors:  Zenei Arihara; Kanako Sakurai; Satsuki Niitsuma; Ryota Sato; Shozo Yamada; Naoko Inoshita; Naoko Iwata; Haruki Fujisawa; Takashi Watanabe; Atsushi Suzuki; Kazuhiro Takahashi; Yoshihisa Sugimura
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.996

8.  Adipsia in a Diabetes Insipidus Patient.

Authors:  Maria Conceição Pereira; Margarida M Vieira; Joana Simões Pereira; Duarte Salgado
Journal:  Case Rep Oncol       Date:  2015-09-10

Review 9.  Juvenile-onset gout and adipsic diabetes insipidus: A case report and literature review.

Authors:  Yun Zhang; Dongmei Wang; Yiding Feng; Wen Zhang; Xuejun Zeng
Journal:  J Int Med Res       Date:  2018-10-01       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.